Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and Madrigal Pharmaceuticals (MDGL)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cardinal Health (CAH – Research Report) and Madrigal Pharmaceuticals (MDGL – Research Report).

Cardinal Health (CAH)

In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on Cardinal Health, with a price target of $115.00. The company’s shares closed last Monday at $103.17.

According to TipRanks.com, Lutz is a 1-star analyst with an average return of -6.1% and a 47.7% success rate. Lutz covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Patterson Companies, and Hims & Hers Health.

Currently, the analyst consensus on Cardinal Health is a Moderate Buy with an average price target of $115.14.

See the top stocks recommended by analysts >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CAH:

• Cardinal Health Ends Pharmaceutical Distribution Deal with OptumRx
• Cardinal Health begins construction of new logistics center in Columbus, Ohio
• Cardinal Health Welcomes Robert Azelby to Board of Directors
• Cardinal Health initiated with an Outperform at Leerink